1/30/2008

The FDA has granted Medtronic approval to market its CGMS iPRO glucose-monitoring device for diabetics. Doctors evaluate the data from the device, which is fastened to a small sensor under the patient's skin, after three days.

Full Story:
Forbes

Related Summaries